How is the enGene Holdings Inc today?

The enGene Holdings Inc today is trading in the down by -7.17% at 2.98.

What is enGene Holdings Inc Annual Net Profit?

enGene Holdings Inc Annual Net Profit rose 44.81% in the last year to $55.14 M. Its sector's average net profit growth for the last fiscal year was 10.15%.

What is enGene Holdings Inc Price to Earning Ratio?

enGene Holdings Inc Price to Earning Ratio is -2.2, which is negative.

What is enGene Holdings Inc Stock Price?

enGene Holdings Inc Stock Price fell 79.48% and underperformed its sector by 101.92% in the past year.

What is enGene Holdings Inc Quarterly Net profit?

enGene Holdings Inc Quarterly Net profit fell 129.82% YoY to $24.62 M. Its sector's average net profit growth YoY for the quarter was 17.65%.

What is enGene Holdings Inc Debt to Equity Ratio?

enGene Holdings Inc Debt to Equity Ratio of 0.09 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

What is enGene Holdings Inc Return on Equity(ROE)?

enGene Holdings Inc Return on Equity(ROE) for the last financial year was -31.96%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is enGene Holdings Inc Mutual Fund Holding?

enGene Holdings Inc Mutual Fund Holding decreased by 0.03% in the last quarter to 3.33.

What is enGene Holdings Inc Interest Coverage Ratio?

enGene Holdings Inc Interest Coverage Ratio is -18.71, lesser than one. This means that it is unable to pay interests with its earnings (EBIT).

What is enGene Holdings Inc Institutional Holding?

enGene Holdings Inc Institutional Holding decreased by 0.02% in the last quarter to 83.02.

enGene Holdings Inc XNAS: ENGN

enGene Holdings Inc Live Share Price Today, Share Analysis and Chart

Name: enGene Holdings Inc: Is Infosys Ltd. worth buying?
Item: enGene Holdings Inc
Rating: 0.81875
Author: Trendlyne DVM scores

about

enGene Holdings Inc is a clinical-stage biotechnology company focused on developing gene therapies to improve the lives of patients. The Company is developing non-viral gene therapies based on its novel and proprietary dually derived chitosan, or DDX...

2.98 -0.23 (-7.17%)

New 52W Low today

28,459 XNAS Volume

High volume+loss today

XNAS 09 May, 2025 3:14 PM (EDT)

Not Eligible

-

Expensive Valuation

15.5 / 100

Technically Bearish

17.3 / 100

No estimates available

enGene Holdings Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

enGene Holdings Inc FAQ

How is enGene Holdings Inc today?

enGene Holdings Inc today is trading in the red, and is down by -7.17% at 2.98.

How has enGene Holdings Inc performed historically?

enGene Holdings Inc is currently trading down -7.17% on an intraday basis. In the past week the stock fell -21.78%. stock has been down -52.77% in the past quarter and fell -79.48% in the past year. You can view this in the overview section.